Some patients in a clinical trial of one new drug lost so much weight that they became concerned and dropped out.

While one benefit that is claimed to come from intermittent fasting is weight control, other benefits such as reduced risks of cancer and type 2 diabetes have been well described. Other potential ...

“I want the weight off and it’s coming off!” the Grammy winner said ...

Demand for GLP-1 drugs continues to climb, boosted by a major price drop and the FDA’s approval of an oral Wegovy pill that ...

Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy on Saturday — two ...

This article was reviewed by Darragh O’Carroll, MD. Key Takeaways: GLP-1s are used for type 2 diabetes, as well as weight loss in people with obesity ...

Stopping prescription weight loss drugs often leads to significant weight regain, according to a large-scale analysis of 11 global studies. Researchers found that although these medications, including ...

Researchers report that intermittent fasting is no more effective for weight loss than other dietary routines. Experts say ...

University of Maryland Medical System surgeons break down how weight loss surgery works, who qualifies and what patients can ...

The sustainability of weight-loss drugs is under scrutiny as new research shows that people who stop taking glucagon-like peptide-1 (GLP-1) agonists regain the pounds at a steady rate, returning to ...

Add Yahoo as a preferred source to see more of our stories on Google. Novo Nordisk’s oral semaglutide. (Novo Nordisk/FDA) Americans now have access to the pill form of weight loss medication Wegovy, ...

More than 3% weight loss is linked to improved liver histology and MASH resolution regardless of baseline BMI.